MedTrace Logo

Antipsychotic Polypharmacy: Prevalence, Background and Consequences

NCT00541398 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 222

Last updated 2009-11-02

No results posted yet for this study

Summary

The primary purpose of the study is to investigate whether an intensive educational intervention can reduce the use of antipsychotic polypharmacy. It is hypothesised that the use of antipsychotic polypharmacy is, in some degree, dependent on non-patient related factors.

Conditions

Interventions

BEHAVIORAL

Implementation of guideline

Outreach visits with interactive education for health staff

Sponsors & Collaborators

  • National Board of Health, Denmark

    collaborator OTHER_GOV

  • Glostrup University Hospital, Copenhagen

    lead OTHER

Principal Investigators

  • Birte Glenthøj, Professor · University of Copenhagen

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2009-01-31
Completion
2009-10-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00541398 on ClinicalTrials.gov